Growing efforts for the testing and approval of superficial radiation therapy by government bodies are key factors contributing to growth prospects.
The Global Superficial Radiation Therapy System Market is anticipated to reach a market value of US$ 43.3 Million in 2022 with a CAGR of 3.8%, indicating significant market growth during the forecast period. The market for superficial radiation therapy systems is anticipated to reach US$ 58.2 Million by the end of 2030, with sales revenue growing at a projected CAGR of 3.8%.
The global coronavirus outbreak is anticipated to have a moderate impact on the industry throughout the pandemic crisis. While the essential nature of basal and squamous cell cancer treatments will support demand. Strict procedures to screen covid-19 patients prior to superficial radiation therapy treatments holds back application rates during this period.
Get a PDF Sample with Latest Market Insights@ https://www.futuremarketinsights.com/reports/sample/rep-gb-5279
“Growing efforts for the testing and approval of superficial radiation therapy by government bodies are key factors contributing to growth prospects. Further, growing consumer bias against invasive treatment options and research investments for oncology will help long-term growth of the industry,” says the FMI study.
Superficial Radiation Therapy System Market – Key Takeaways
Superficial Radiation Therapy System Market – Key Driving Factors
Ask from Market Research Expert@ https://www.futuremarketinsights.com/ask-question/rep-gb-5279
Superficial Radiation Therapy System Market – Key Constraints
The Anticipated Impact of Coronavirus
The superficial radiation therapy systems market has been moderately limited in applications during the coronavirus pandemic. Lockdown restrictions and social distancing guidelines have resulted in delayed appointments for superficial radiation therapy treatments. Disinfection requirements and strict screening for covid-19 cases, restricts access to patients and hurts operation rates limiting demand for superficial radiation therapy systems in the short term. Recovery is highly dependent on the timeline to bring the pandemic under control.
Competition Landscape
Major manufacturers in the superficial radiation therapy system market include but are not limited to Nordion Inc., Sensus Healthcare, Xstrahl Ltd., SkinCure, IsoRay Inc., Mevion Medical Systems, Mitsubishi Electric Corp., Varian Medical Systems, Electa AB, Ion Beam Applications, and RaySearch Laboratories.
Superficial radiation therapy system manufacturers have been investing in strategic collaborations and acquisitions for product innovation and manufacturing capability enhancements.
For more Report Customization, connect with us at@ https://www.futuremarketinsights.com/customization-available/rep-gb-5279
For instance, Sensus Healthcare has announced the acquisition of Aesthetic Laser Partners and Aesthetic Mobile Laser Services for dermatology capabilities including superficial radiation therapy systems. IntraOp Medical Corp. has entered into a partnership with the Lausanne University Hospital for clinical trials of FLASH radiotherapy which includes superficial radiation therapy functionality. Also, Stratpharma Inc. has joined hands with Sensus Healthcare for development of topical medical products including superficial radiation therapy systems.
Superficial Radiation Therapy System Market By Category
By Product Type :
By Application :
Use promo code >> FMITODAY to get flat 20% discount
By End User :
By Region :
Future Market Insights, Inc. (ESOMAR certified, Stevie Award - recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market.
Jun 08, 2023